RMI2 and breast cancer: Among the most significant, we found the amplification of the region 16p, which harbors genes such as SNN, LITAF, ZC3H7A, TXNDC11, RMI2 and the oncogene BCAR4, implicated in endocrine resistance in human BC cell.